Home › Funds › CAXTON CORP › XFOR

CAXTON CORP position in XFOR

X4 PHARMACEUTICALS INC · Health Care

CAXTON CORP reported holding 15,557 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$73K, representing 3.92% of its reported portfolio and ranking #8 among its reported holdings. CAXTON CORP has disclosed XFOR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)15.56K sh
Reported value held$72.65K
Portfolio Weight3.92%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAXTON CORP's XFOR position evolved

CAXTON CORP first disclosed a stake in XFOR in Q4 2025 at 15,557 shares (US$62K). The position peaked in Q2 2026 at 15,557 shares, worth US$73K. Across 3 filings, CAXTON CORP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 15,557 shares valued at US$73K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.56K $62.23K New
Q1 2026 15.56K $64.25K Hold
Q2 2026 15.56K $72.65K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XFOR and 13F data

XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XFOR

All XFOR fund holders →

FAQ

How long has CAXTON CORP held XFOR?

CAXTON CORP has disclosed XFOR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is CAXTON CORP's current position in XFOR?

As of Q2 2026, CAXTON CORP holds 15.56K shares of XFOR (X4 PHARMACEUTICALS INC), valued at $72.65K, representing 3.92% of its reported portfolio and ranking #8.

Has CAXTON CORP been buying or selling XFOR?

In the latest 13F filing (Q2 2026), CAXTON CORP held unchanged its position in XFOR. The position peaked in Q2 2026 at 15.56K shares.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.